Lindynette (Ethinylestradiol, Gestodene)

Ethinylestradiol (an estrogen) and gestodene (a progestogen) work together to inhibit the release of luteinizing hormone and follicle‑stimulating hormone from the pituitary gland. This blocks ovulation, thickens cervical mucus, and creates an endometrial environment that is unfavorable for implantation.

The dosing regimen for Lindynette is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily, at the same time each day, but the exact schedule should follow the prescriber’s instructions.

Lindynette is contraindicated during pregnancy because it is intended to prevent conception, not to treat an existing pregnancy. While limited data exist for breastfeeding, most guidelines advise caution and recommend discussing alternatives with a healthcare provider.

To order Lindynette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lindynette contains gestodene, a third‑generation progestogen, which may offer a lower incidence of androgenic side effects such as acne compared with older agents like levonorgestrel. Efficacy in preventing pregnancy is comparable across combined oral contraceptives when taken correctly.

Lindynette tablets should be stored at ambient temperature, below 25 °C, in their original blister pack to protect from moisture and light. Keep the medication out of reach of children and do not use after the expiry date.

Lindynette is taken orally as a single tablet each day, preferably at the same time each day. It can be taken with or without food. If a dose is missed, follow the product’s guidance or consult a healthcare professional.

The most serious risks include venous or arterial thromboembolism (blood clots), severe hypertension, and rare liver disorders such as cholestatic jaundice or hepatic adenoma. Patients should seek immediate medical attention if they experience unexplained leg pain, chest pain, severe headache, or jaundice.

Lindynette should not be used by women who are pregnant, have a history of thromboembolic disease, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or who are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to any component of the tablet.